August 12, 2021

Voxelotor is a hemoglobin oxygen-affinity modulator that is used to treat sickle cell disease. This study, published in Annals of Pharmacotherapy, conducted a comprehensive literature review on the safety, efficacy, and affordability of voxelotor. Ultimately, it was found that voxelotor is generally well-tolerated and significantly increases mean hemoglobin level compared to placebo. Commonly noted adverse...